The largest database of trusted experimental protocols

41 protocols using thromborel s

1

Coagulation Profile Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Coagulation profiles, including prothrombin time using Thromborel S (Sysmex Co., Kobe, Japan), aPTT, prothrombin time-international normalized ratio, fibrinogen level (Clauss method) using Thrombocheck (Sysmex Co., Kobe, Japan), and antithrombin (AT) activity using Revohem AT (Sysmex Co., Kobe, Japan), were analyzed in the central hematological laboratory using XN-3000 (Sysmex Co., Kobe, Japan) according to the institutional protocol. Clotting factors II, VIII, IX, and X were determined by CS-5100 (Sysmex, Kobe, Japan) using Thromborel S, Pathromtin SL, Pathromtin SL, and Thromborel S, respectively (Siemens Healthineers, Marburg, Germany). All clotting factors were measured using a one-stage clotting assay in individual factor-deficient plasma (Siemens Healthineers, Marburg, Germany).
+ Open protocol
+ Expand
2

Neutrophil Serine Protease Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human neutrophil elastase (HNE) (EC.3.4.21.37), human neutrophil proteinase 3 (PR3) (EC.3.4.21.76), and human neutrophil cathepsin G (CG) (EC.3.4.21.20) were acquired from Calbiochem Ltd. (San Diego, USA). The unfractionated heparin (Hepamax-S®, Porcine) was obtained from Blau Pharmaceutical (Cotia, SP, Brazil). MeO-Suc-Ala-Ala-Pro-Val-pNan, MeO-Suc-Ala-Ala-Pro-Phe-pNan, and MeO-Suc-Ala-Ala-Pro-Val-pNan were acquired from Calbiochem Ltd. (San Diego, USA). The PT and aPTT reagents (Thromborel S and Dade Actin Activated Cephaloplastin reagent) were obtained from Dade Behring (Marburg, Germany). All other used reagents were of analytical grade.
+ Open protocol
+ Expand
3

Abalone Extract Anticoagulant Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
To measure PT, 100 μL citrated plasma was added to a glass clotting tube and incubated at 37 °C on the heating block of a Hyland-Clotek clotting machine for 5 min. 50 μL saline (negative control), heparin/Clexane (positive control) or diluted abalone extracts or AEC pooled fractions were added to the tube. The volume was adjusted to 150 μL with plasma before the final addition of 100 μL Thromborel S® (Dade Behring Inc. Newark, NJ, USA) to initiate clotting. Time in seconds until clot formation was measured in triplicate and expressed as the mean ± standard error.
+ Open protocol
+ Expand
4

Comprehensive Hematological and Coagulation Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following tests were done on all patients and controls: Complete blood counts (Automated hematology analyser LH500), biochemical parameters including serum calcium, creatinine and total proteins, β-2 microglobulin, hemostatic parameters including prothrombin time (PT; Dade Behring Thromborel S), activated partial thromboplastin time (APTT; Dade Behring Actin FS), thrombin time (TT; Sigma- Aldrich), plasma fibrinogen (Quantia, Tulip), factor VIII assay (PZ Cormay S.A.), D-dimer (Zymutest, Hyphen Biomed) and LA (dRVVT screening and confirmatory test, Tulip).
+ Open protocol
+ Expand
5

Herb Extracts for Coagulation Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Extracts from 114 Chinese medical herbs were supplied by the Cooperative Research Project at the Joint Usage/Research Center (Joint Usage/Research Center for Science-Based Natural Medicine), Institute of Natural Medicine, University of Toyama [Table 1]. Human factor XII was purchased from Hematologic Technologies Inc. (Essex Junction, Vermont, USA). Pooled normal human plasma was obtained from Axis-Shield (Oslo, Norway). The coagulation assay reagent, Thromborel S was purchased from Dade Behring (Marburg, Germany) and Sysmex (Kobe, Japan), respectively.
+ Open protocol
+ Expand
6

Platelets and Thrombin Generation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The contribution of platelets to local thrombin generation was evaluated in a cell-based model of thrombin generation primed by platelets, using a fluorogenic assay (Technoclone GmBH, Austria) as previously described11 (link). Briefly, this cell-based model consists of isolated platelets at 1 × 106 platelets/µL from controls or treated blood samples resuspended in Hanks' balanced salt solution, with platelets or plasma always from the same participant. Thrombin generation was initiated by the addition of 1.1 pM tissue factor exposed on phospholipids micelles (Thromborel®S, Dade Behring, Marburg GmbH, Germany), and a fluorogenic substrate that also contains CaCl2 to favor the activation of coagulation mechanisms. The fluorescence generated was evaluated at a wavelength of 390 nm/450 nm (excitation/emission) for 90 min (at intervals of 1 min) and fluorescence units were analyzed with the Thermo Fluoroskan Ascent Software (Technoclone GmbH). Parameters assessed in our studies were lag time (min), maximum thrombin peak (nM), time to achieve this peak (min), and the total amount of thrombin generated as the area under the curve (arbitrary units).
+ Open protocol
+ Expand
7

Fluorescent Labeling of Thrombi

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh citrated blood from healthy volunteers was centrifuged at 180 g for 10 minutes to obtain platelet-rich plasma (PRP). Every mL of PRP was added 5 μL of tissue thrompolastin, thromborel S (Dade Behring) and 25μL of 1M CaCl2 for 15 minutes at 37 oC to induce thrombus formation. Thrombi were then incubated with either 2 μg/mL of Targ-Cy7 or Mut-Cy7 in 1 mL of PBS for an hour at room temperature with gentle mixing. The thrombi were then washed five times with PBS to remove unbound fluoroprobe. The fluorescence intensities of the thrombi were analysed using the Odyssey® CLx Infrared Imaging System (700 nm/800 nm; LI-COR Biotechnology, USA).
+ Open protocol
+ Expand
8

Purification and Characterization of Bovine Trypsin and Human Plasma Kallikrein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bovine trypsin was purchased from Roche (Mannheim, Germany) and human plasma kallikrein (PKa) was purified in the Laboratory of Chemistry and Protein Function using the protocol established by Prof. Dr. Maria Luiza Vilela Oliva and colleagues in 1982 [14 ].
The substrates Boc-Glu(Obzl)-Ala-Arg-AMC.HCl, Bz-DL-Arg-pNA.HCl and H-D-Pro-Phe-Arg-pNa were purchased from Bachem (Bubendorf, Switzerland). Thromborel S, thrombin, and Dade actin-activated cephaloplastin were obtained from Dade Behring (Marburg, Germany), and heparin was obtained from Roche (liquenime®). Rose Bengal (3,4,5,6 tetrachloro-2,4,5,7-tetraiodofluorescein) and rhodamine 6G were purchased from Sigma Aldrich (Saint Louis, MO, USA). ADP, arachidonic acid, and collagen I were obtained from Chrono-log (Pennsylvania, CA, USA).
+ Open protocol
+ Expand
9

Preoperative and Postoperative Coagulation Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Prothrombin time, aPTT and INR, preoperative and postoperative Hb values were
obtained from blood samples. Prothrombin time test measures how long it takes
for a clot to form in a blood sample; and it was determined by coagulometric
method using Thromborel S (Dade Behring OUHP G29) kit, at 405 nm wavelength with
an optical reader. Activated partial thromboplastin time was determined using
Pathromtin SL (Dade Behring OQGS G17) kit, coagulometric method, at 405 nm
wavelength with an optical reader10 (link),11 (link). An INR is a type of calculation based
on PT test results. Hemoglobin was detected in EDTA tubes by using blood counter
(Beckman Coulter HMX California/USA) device.
+ Open protocol
+ Expand
10

Evaluating FVII Variant Coagulant Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
The abilities of FVII variants on coagulant activity were examined by a modified PT assay using lyophilized human placental thromboplastin, Thromborel S (Siemens) as the activator in lyophilized human FVII–deficient plasma (Siemens). FVII samples (5 nM) were added to FVII-deficient plasma. The reaction was initiated by the addition of Thromborel S reagent into the mixture. The time to clot formation was recorded on the semiautomated coagulation analyzer CA-104 (Sysmex Europe GmbH, Norderstedt, Germany).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!